Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells (Q35130666)

6 August 2017

title

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells (English)

1 reference

6 August 2017

author

Martin Hrabě de Angelis

19

Martin Hrabě de Angelis

0 references

Valérie Gailus-Durner

14

Valérie Gailus-Durner

0 references

Julia Calzada-Wack

7

Julia Calzada-Wack

1 reference

6 August 2017

Jan Rozman

9

0 references

Martin Klingenspor

Martin Klingenspor

15

0 references

Eckhard Wolf

Eckhard Wolf

16

0 references

Irene Esposito

12

Irene Esposito

1 reference

6 August 2017

Monika Raab

1

1 reference

6 August 2017

Sven Kappel

2

1 reference

6 August 2017

Andrea Krämer

3

1 reference

6 August 2017

Mourad Sanhaji

4

1 reference

6 August 2017

Yves Matthess

5

1 reference

6 August 2017

Elisabeth Kurunci-Csacsko

6

1 reference

6 August 2017

Birgit Rathkolb

8

1 reference

6 August 2017

Thure Adler

10

1 reference

6 August 2017

Dirk H Busch

11

1 reference

6 August 2017

Helmut Fuchs

13

1 reference

6 August 2017

Nicole Sänger

17

1 reference

6 August 2017

Florian Prinz

18

1 reference

6 August 2017

Jost Seibler

20

1 reference

6 August 2017

Juping Yuan

21

1 reference

6 August 2017

Martin Bergmann

22

1 reference

6 August 2017

Rainald Knecht

23

1 reference

6 August 2017

Bertolt Kreft

24

1 reference

6 August 2017

Klaus Strebhardt

25

1 reference

6 August 2017

language of work or name

English

0 references

publication date

19 July 2011

1 reference

6 August 2017

published in

Nature Communications

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

page(s)

395

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

6 August 2017

copyright license

start time

19 July 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Shared and separate functions of polo-like kinases and aurora kinases in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Cdk1/Cyclin B1 Controls Fas-Mediated Apoptosis by Regulating Caspase-8 Activity

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

The Plk1 inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in mitosis and generates aneuploidy in vitro

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Res

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Genetically engineered mouse models in cancer research

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

T cell receptor "inside-out" pathway via signaling module SKAP1-RapL regulates T cell motility and interactions in lymph nodes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Polo-like kinases: conservation and divergence in their functions and regulation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Polo-like kinase 1 is essential for early embryonic development and tumor suppression

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Genetic influence on immune phenotype revealed strain-specific variations in peripheral blood lineages

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Assessing iron status: beyond serum ferritin and transferrin saturation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

The spindle-assembly checkpoint in space and time

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Reversible gene knockdown in mice using a tight, inducible shRNA expression system

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Targeted anti-mitotic therapies: can we improve on tubulin agents?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

The mighty mouse: genetically engineered mouse models in cancer drug development

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Normal cells, but not cancer cells, survive severe Plk1 depletion

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Single copy shRNA configuration for ubiquitous gene knockdown in mice

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Polo-like kinases and oncogenesis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Polo-like kinases and the orchestration of cell division

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Cancer modeling in the modern era: progress and challenges

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

All you wanted to know about spermatogonia but were afraid to ask.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Genetic and epigenetic changes in human epithelial cells immortalized by telomerase

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Drosophila polo kinase is required for cytokinesis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Human Prk is a conserved protein serine/threonine kinase involved in regulating M phase functions

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Plk is a functional homolog of Saccharomyces cerevisiae Cdc5, and elevated Plk activity induces multiple septation structures

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Polo-like kinase, a novel marker for cellular proliferation.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Density-Dependent Inhibition of Mouse Embryo Fibroblast Growth: Involvement of IGFBP-3

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

polo, a mitotic mutant of Drosophila displaying abnormal spindle poles.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144583

Paul Ehrlich's magic bullet concept: 100 years of progress

13 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Targeting polo-like kinase 1 for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Identification of high risk breast-cancer patients by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Silencing of mammalian genes by tetracycline-inducible shRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Introducing the German Mouse Clinic: open access platform for standardized phenotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

The POLO kinase is required at multiple stages during spermatogenesis in Drosophila melanogaster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Targeting polo-like kinase: learning too little too late?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Damaging effect of taxol on mouse spermatogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS1395

From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research

21 January 2018

1 reference

12 December 2020

Rational combinations of siRNAs targeting Plk1 with breast cancer drugs

1 reference

12 December 2020

Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells

1 reference

12 December 2020

Duration of the Cycle of the Seminiferous Epithelium in the Mouse and Hamster Determined by Means of 3H-Thymidine and Radioautography

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCOMMS1395

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference